Athersys Inc (ATHX.OQ) Insider Trading | Reuters.com
Edition:
United States

Insider Trading: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.08USD
28 Jun 2016
Change (% chg)

-- (--)
Prev Close
$2.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,647
52-wk High
$2.89
52-wk Low
$0.94

ORBIMED ADVISORS L L C

Institutional Holders

% Shares Owned: 24.97%
# of Holders: 71
Total Shares Held: 21,064,289
3 Mo. Net Change: 6,228,408
# New Positions: 23
# Closed Positions: 5
# Increased Positions: 38
# Reduced Positions: 15
# Net Buyers: 23

Officers & Directors

Name Age Since Current Position

Gil Bokkelen

54 2000 Chairman of the Board, Chief Executive Officer

William Lehmann

49 2006 President, Chief Operating Officer

John Harrington

47 2007 Executive Vice President, Chief Scientific Officer, Director

Robert Deans

63 2011 Executive Vice President - Regenerative Medicine

Laura Campbell

51 2006 Vice President - Finance

Lee Babiss

59 2013 Lead Independent Director

Ismail Kola

59 2010 Independent Director

Lorin Randall

72 2007 Independent Director

Kenneth Traub

54

Jack Wyszomierski

59 2010 Independent Director